We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Portable, Ultra-Low-Field MRI System Brings Brain Imaging to Patient’s Bedside

By MedImaging International staff writers
Posted on 10 Oct 2023
Print article
Image: Advanced AI algorithms are now integrated across all Swoop ultra-low-field brain imaging system sequences (Photo courtesy of Hyperfine)
Image: Advanced AI algorithms are now integrated across all Swoop ultra-low-field brain imaging system sequences (Photo courtesy of Hyperfine)

Using fixed MRI machines often presents challenges for healthcare providers and patients, particularly when immediate action is needed. There's always a need to balance the useful insights that imaging might provide against the risks associated with transferring patients for MRI scans, such as treatment delays and therapy interruptions. Now, the world’s first FDA-cleared portable magnetic resonance brain imaging system has received clearance for an updated software that brings image quality enhancements to its diffusion-weighted imaging (DWI) sequence.

Hyperfine’s (Guilford, CT, USA) Swoop Portable MR Imaging System takes diagnostic MR scans right to the patient's location. This has the potential to shorten ICU stays and their associated costs by enabling quicker diagnosis and reducing interruptions in patient care. For hospitals, using the Swoop system in the ICU allows for more effective staff allocation. It minimizes the logistics involved in moving patients for imaging, freeing up staff to focus on immediate patient needs in the ICU or assist other patients. Moreover, compared to traditional MRI systems, the Swoop can deliver results three to seven hours faster.

The Swoop system originally received its FDA clearance in 2020 as a portable magnetic resonance brain imaging device designed to generate brain images in situations where a complete diagnostic examination might not be clinically feasible. The latest software update expands the Swoop system’s AI denoising capabilities by integrating advanced image post-processing into the DWI sequence. This enhanced imaging clarity could potentially allow healthcare providers to make more precise diagnoses and treatment plans for patients requiring brain scans. Hyperfine plans to roll out the updated Swoop system software over the coming months. The Swoop system has received approval for brain imaging in countries such as Canada and Australia, UKCA certification in the United Kingdom, and CE certification in the European Union, and is also available in New Zealand.

“We believe in making brain imaging more accessible, clinically relevant, and actionable. We continue to make meaningful progress across all sequences. With this significant and most recent update, we now incorporate deep learning into our DWI sequence,” said Tom Teisseyre, chief operating officer of Hyperfine, Inc. “These imaging improvements will serve a critical role in enhancing image quality for healthcare professionals in time-sensitive environments.”

Related Links:
Hyperfine 

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Computed Tomography (CT) Scanner
Aquilion Serve SP
New
Brachytherapy Planning System
Oncentra Brachy
New
Dose Area Product Meter
VacuDAP

Print article
Radcal

Channels

Radiography

view channel
Image: LumiGuide enables doctors to navigate through blood vessels using light instead of X-ray (Photo courtesy of Philips)

3D Human GPS Powered By Light Paves Way for Radiation-Free Minimally-Invasive Surgery

In vascular surgery, doctors frequently employ endovascular surgery techniques using tools such as guidewires and catheters, often accessing through arteries like the femoral artery. This method is known... Read more

Ultrasound

view channel
Image: Intravascular ultrasound provides a more accurate and specific picture of the coronary arteries (Photo courtesy of 123RF)

Intravascular Imaging Significantly Improves Outcomes in Cardiovascular Stenting Procedures

Individuals with coronary artery disease, which involves plaque accumulation in the arteries leading to symptoms like chest pain, shortness of breath, and heart attacks, often undergo a non-surgical procedure... Read more

Nuclear Medicine

view channel
Image: The PET imaging technique can noninvasively detect active inflammation before clinical symptoms arise (Photo courtesy of 123RF)

New PET Tracer Detects Inflammatory Arthritis Before Symptoms Appear

Rheumatoid arthritis, the most common form of inflammatory arthritis, affects 18 million people globally. It is a complex autoimmune disease marked by chronic inflammation, leading to cartilage and bone... Read more

General/Advanced Imaging

view channel
Image: Routine chest CT holds untapped potential for revealing patients at risk for cardiovascular disease (Photo courtesy of Johns Hopkins)

Routine Chest CT Exams Can Identify Patients at Risk for Cardiovascular Disease

Coronary artery disease (CAD) is the primary cause of death globally. Adults without symptoms but at risk can be screened using EKG-gated coronary artery calcium (CAC) CT scans, which are crucial in assessing... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: The acquisition will expand IBA’s medical imaging quality assurance offering (Photo courtesy of Radcal)

IBA Acquires Radcal to Expand Medical Imaging Quality Assurance Offering

Ion Beam Applications S.A. (IBA, Louvain-La-Neuve, Belgium), the global leader in particle accelerator technology and a world-leading provider of dosimetry and quality assurance (QA) solutions, has entered... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.